Taking the brakes off of the most powerful weapon in the fight against cancer: our immune system
INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer.
Our drug candidates, INKmuneTM and INB03, may be used alone or with conventional therapies to help eliminate disease in a wide variety of cancers. We believe they can also boost the effectiveness of other immunotherapies designed to enhance immune response to specific tumors.
The development of new immunotherapies is revolutionizing cancer care. INmune Bio is at the forefront of that revolution with novel products that take the brakes off of the most powerful weapon in the fight against cancer: the patient’s immune system.